Skip Navigation

Limited Stage Small Cell Lung Cancer LS-SCLC: A Phase III Randomized Study of Chemoradiation versus Chemoradiation plus Atezolizumab

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT03811002

Study #:
STUDY00144305

Start Date:
Oct 07, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03811002

View Complete Trial Details & Eligibility at ClinicalTrials.gov